Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Holl
BICENTRIC PILOT STUDY ON AGE-ADAPTED HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA PATIENTS > 65 YEARS - MARiTA TRIAL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Results of Stimulation Treatments at the Geothermal Research Wells in Groß Schönebeck, Germany
Related publications
High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma
Neurology
Neurology
Frontline Therapy Results in Unselected Primary CNS Lymphoma Patients Without Consolidation Hd Chemotherapy Followed by Autologous Stem Cell Transplantation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Should Eligible Patients With T-Cell Lymphoma Receive High-Dose Therapy and Autologous Stem Cell Transplant in the Upfront Setting?
Current Oncology Reports
Oncology
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Evaluation of High-Dose Melphalan Toxicity by Age in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Cardiorespiratory Fitness in Long-Term Lymphoma Survivors After High-Dose Chemotherapy With Autologous Stem Cell Transplantation
British Journal of Cancer
Cancer Research
Oncology
High-Dose Chemotherapy With Thiotepa, Busulfan, and Cyclophosphamide and Autologous Stem Cell Transplantation for Patients With Primary Central Nervous System Lymphoma in First Complete Remission
Cancer
Cancer Research
Oncology
Dose Intensity and Autologous Stem Cell Transplantation as Salvage Therapy for Pediatric Primary CNS Malignancies
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial
British Journal of Haematology
Hematology
